You are here

  • Dhoot R, Humphrey JM, O'Meara P, Gardner A, McDonald CJ, Ogot K, Antani SK, Abuya J, Kohli M. Implementing a mobile diagnostic unit to increase access to imaging and laboratory services in western Kenya. BMJ Glob Health. 2018 Oct 8;3(5):e000947. doi: 10.1136/bmjgh-2018-000947. eCollection 2018.
  • Coakley M, Hurt D, Weder N, Mtingwa M, Fincher EC, Alekseyev V, Chen D, Yun A, Gizaw M, Swan J, Yoo TS, Huyen Y. The NIH 3D Print Exchange: A Public Resource for Bioscientific and Biomedical 3D Prints 3D Print Additive Manufacturing, Sep. 1, 2014, 1(3):137-140.
  • Zarin D, Tse T, Sheehan J. The proposed rule for U.S. clinical trial registration and results submission. N Engl J Med. 2015 Jan 8;372(2):174-80. doi: 10.1056/NEJMsr1414226. Epub 2014 Dec 24.
  • Hess CN, Roe MT, Gibson CM, Temple RJ, Pencina MJ, Zarin DA, Anstrom KJ, Alexander JH, Sherman RE, Fiedorek FT, Mahaffey KW, Lee KL, Chow SC, Armstrong PW, Califf RM. Independent data monitoring committees: preparing a path for the future. Am Heart J. 2014 Aug;168(2):135-41.e1. doi: 10.1016/j.ahj.2014.05.003. Epub 2014 May 15.
  • Hartung DM, Zarin D, Guise JM, McDonagh M, Paynter R, Helfand M. Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications. Ann Intern Med. 2014 Apr 1;160(7):477-83. doi: 10.7326/M13-0480.
  • Candemir S, Jaeger S, Palaniappan K, Musco J, Singh RK, Xue Z, Karargyris A, Antani SK, Thoma GR, McDonald CJ. Lung segmentation in chest radiographs using anatomical atlases with nonrigid registration. IEEE Trans Med Imaging. 2014 Feb;33(2):577-90. doi: 10.1109/TMI.2013.2290491. Epub 2013 Nov 13.
  • Caudle KE, Klein TE, Hoffman JM, Muller DJ, Whirl-Carrillo M, Gong L, McDonagh EM, Sangkuhl K, Thorn CF, Schwab M, Agundez JA, Freimuth RR, Huser V, Lee MT, Iwuchukwu OF, Crews KR, Scott SA,, Wadelius M, Swen JJ, Tyndale RF, Stein CM, Roden D, Relling MV, Williams MS, Johnson SG. Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process. Curr Drug Metab. 2014 Feb;15(2):209-17.
  • Zarin D. Participant-level data and the new frontier in trial transparency [Letter]. N Engl J Med. 2013 Aug 1;369(5):468-9. doi: 10.1056/NEJMe1307268.
  • Zarin D, Tse T. Trust but verify: trial registration and determining fidelity to the protocol [Letter]. Ann Intern Med. 2013 Jul 2;159(1):65-7. doi: 10.7326/0003-4819-159-1-201307020-00011.
  • Zarin D, Tse T. Clarification about ClinicalTrials.gov [Letter]. IRB. 2013 May-Jun;35(3):19.
  • Zarin DA, Williams RJ, Bergeris AM, Dobbins H, Ide NC, Loane RF, Robbins A, Tse T. ClinicalTrials.gov and Related Projects: Improving Access to Information about Clinical Trials April 2013 Technical Report to the LHNCBC Board of Scientific Counselors
  • Zarin DA, Tse T. Unambiguous identification of obesity trials [Letter]. N Engl J Med. 2013 Feb 7;368(6):580-1. doi: 10.1056/NEJMc1215018.
  • Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. JAMA. 2012 May 2;307(17):1838-47. doi: 10.1001/jama.2012.3424.
  • Zarin D. Factual Errors about ClinicalTrials.gov and other federal mandates in special report by Shuster [Letter]. Clin Transl Sci. 2012 Apr;5(2):217; author reply 217. doi: 10.1111/j.1752-8062.2012.00410.x.
  • Ross JS, Tse T, Zarin DA, Xu H, Zhou L, Krumholz HM. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ. 2012 Jan 3;344:d7292. doi: 10.1136/bmj.d7292.
  • Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database--update and key issues. N Engl J Med. 2011 Mar 3;364(9):852-60. doi: 10.1056/NEJMsa1012065.
  • Zarin DA, Califf R. Point Counterpoint: ClinicalTrials.gov: Bureaucratic Nuisance or Opportunity to Improve the Field? APOR 2010 Nov; 6 (2): 3-5
  • Willams RJ, Tse T, Harlan WR, Zarin DA. Registration of observational studies: is it time? CMAJ. 2010 Oct 19;182(15):1638-42. doi: 10.1503/cmaj.092252. Epub 2010 Jul 19.
  • Dawson L, Zarin DA, Emanuel EJ, Friedman LM, Chaudhari B, Goodman SN. Considering usual medical care in clinical trial design. PLoS Med. 2009 Sep;6(9):e1000111. doi: 10.1371/journal.pmed.1000111. Epub 2009 Sep 29.
  • Tse T, Williams RJ, Zarin DA. Reporting "basic results" in ClinicalTrials.gov. Chest. 2009 Jul;136(1):295-303. doi: 10.1378/chest.08-3022.
  • Tse T, Williams RJ, Zarin DA. Update on Registration of Clinical Trials in ClinicalTrials.gov. Chest. 2009 Jul;136(1):304-5. doi: 10.1378/chest.09-1219.
  • Zarin DA. Clinical trials registry expands. Interview by Bridget M. Kuehn. JAMA. 2009 Jul 1;302(1):22. doi: 10.1001/jama.2009.891.
  • Tse T, Zarin DA. Clinical Trial Registration and Results Reporting: ClinicalTrials.gov and FDAAA FDLI Update. 2009 Jan/Feb;1:18-22
  • Zarin DA, Tse T. Tracking health services research studies [Letter]. JAMA. 2008 Nov 19;300(19):2252; author reply 2252. doi: 10.1001/jama.2008.612.
  • Zarin DA, Tse T. Moving Towards Transparency of Clinical Trials Science. 2008 Mar 7;319(5868):1340-2.

Pages